4.8 Article

A Multi-Bioactive Nanomicelle-Based One Stone for Multiple Birds Strategy for Precision Therapy of Abdominal Aortic Aneurysms

Journal

ADVANCED MATERIALS
Volume 34, Issue 44, Pages -

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/adma.202204455

Keywords

aneurysms; bioactive conjugates; inflammation; nanotherapy; reactive oxygen species

Funding

  1. National Natural Science Foundation of China [81971727, 32271451]
  2. Special Project of Central Government Guiding Local Science and Technology Development in Hubei Province [2020ZYYD002]
  3. Program for Scientific and Technological Innovation Leader of Chongqing [CQYC20210302362]
  4. Program for Distinguished Young Scholars of TMMU

Ask authors/readers for more resources

This study reports a multi-effect strategy for the treatment of AAA by designing and synthesizing nanomicelles that can simultaneously inhibit migration and activation of inflammatory cells, protect vascular smooth muscle cells from oxidative stress, calcification, and apoptosis. These nanomicelles effectively delay AAA expansion and show notable distribution and therapeutic effects in AAA tissue. Additionally, the nanomicelles can serve as a bioactive nanoplatform for delivering and releasing anti-aneurysmal drugs, offering effective therapy for AAA and other inflammatory vascular diseases.
Abdominal aortic aneurysm (AAA) remains a lethal aortic disease in the elderly. Currently, no effective drugs can be clinically applied to prevent the development of AAA. Herein, a one stone for multiple birds strategy for AAA therapy is reported. As a proof of concept, three bioactive conjugates are designed and synthesized, which can assemble into nanomicelles. Cellularly, these nanomicelles significantly inhibit migration and activation of inflammatory cells as well as protect vascular smooth muscle cells (VSMCs) from induced oxidative stress, calcification and apoptosis, with the best effect for nanomicelles (TPTN) derived from a conjugate defined as TPT. After intravenous delivery, TPTN efficiently accumulates in the aneurysmal tissue of AAA rats, showing notable distribution in neutrophils, macrophages and VSMCs, all relevant to AAA pathogenesis. Whereas three examined nanomicelles effectively delay expansion of AAA in rats, TPTN most potently prevents AAA growth by simultaneously normalizing the pro-inflammatory microenvironment and regulating multiple pathological cells. TPTN is effective even at 0.2 mg kg(-1). Besides, TPTN can function as a bioactive nanoplatform for site-specifically delivering and triggerably releasing anti-aneurysmal drugs, affording synergistic therapeutic effects. Consequently, TPTN is a promising multi-bioactive nanotherapy and bioresponsive targeting delivery nanocarrier for effective therapy of AAA and other inflammatory vascular diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available